Presentation is loading. Please wait.

Presentation is loading. Please wait.

By Georges Metellus, M.D., M.P.H. American University of Antigua Miami Site.

Similar presentations

Presentation on theme: "By Georges Metellus, M.D., M.P.H. American University of Antigua Miami Site."— Presentation transcript:

1 By Georges Metellus, M.D., M.P.H. American University of Antigua Miami Site

2  A. Plasma: Liquid fraction of whole blood (extracellular part)  B. Formed elements : Cellular components suspended in the plasma.  C. Normal volumes of blood: 1. Plasma: 2,6 L 2. Formed elements: 2.4 L 3. Whole Blood: 4 to 6 L average or 7% to 9% of the total body weight.  D. Blood pH: 1. Blood is Alkaline-pH 7.35 to pH Blood pH decreased toward neutral creates a condition called “acidosis”  E. Blood donation: 1. Approximately 14 million units donated annually 2. Plasma volume expanders (such as Albumin) can maintain blood volume after hemorrhage for only short period. 3. Storage of donated blood limited to 6 weeks.

3  A. Types 1. RBCs (erythrocytes) 2. WBCs (Leukocytes) a. Granular leukocytes-neutrophils, eosinophils, and basophils b. Nongranular leukocytes- lymphocytes and monocytes. 3. Platelets or thrombocytes  B. Number 1. RBCs -4.2 to 6.2 million / mm3 of blood 2. WBCs to 10,000 /mm3 of blood 3. Platelets- 150,000 to 400,000 /mm3 of blood  C. Formation 1. Red bone marrow ( myeloid tissue) forms all blood cells except some lymphocytes and monocytes. 2. Most other cells are formed by lymphatic (lymphoid) tissue in the lymph nodes, thymus, and spleen

4  Definition: Erythropoiesis is the production of red blood cells (RBCs) in the bone marrow and is dependent on the release of erythropoietin from the kidneys A. Erythropoiesis and erythropoietin (EPO) 1. Stimuli for EPO release: Hypoxemia- severe anemia- high altitude. EPO accelerates erythropoiesis in the bone marrow by stimulating the erythroid stem cell to divide and therefore increasing the total number of RBCs resulting in an increase of the O2-carrying capacity of blood. B. Epoeitin alfa: is a form of EPO produced by recombinant DNA technology, is frequently abused by athletes to increase their energy level. It also is used in the treatment of anemia associated with renal failure, chronic disease, and chemotherapy.

5  A. RBC, White Blood Cell (WBC), and platelet production (hematopoiesis) occurs outside the bone marrow (1). common sites include the liver and spleen (2). Extramedullary hematopoiesis causes hepatomegaly and splenomegaly  B. Pathogenesis: (1). Intrinsic bone marrow disease (e.g., myelofibrosis. (2). Accelerated erythropoiesis (e.g., severe hemolysis in sickle cell disease) a) expand the bone marrow cavity b) Produces frontal bossing of the skull and “hair-on- end” appearance on radiographs of the skull

6 Blood is identified as a specific “type” by using the ABO and Rh systems of classification.  ABO system: 1. Type A blood: Type A antigens in RBCs; anti-B type antibodies in plasma 2. Type B Blood: Type B antigens in RBCs; anti-A type antibodies in plasma. 3. Type AB blood: Type A and type B antigens in RBCs; no anti-A or anti-B antibodies in plasma 4. Type O blood: no type A or type B antigens in RBCs; both anti-A and anti-B antibodies are present in plasma; called universal donor blood

7  Rh System: 1. Rh-positive blood: Rh factor antigen present in RBCs 2. Rh-negative: no Rh factor present in RBCs; no anti-Rh antibodies present naturally in plasma; anti-Rh antibodies, however, appear in the plasma of Rh-negative persons if Rh-positive RBCs have been introduced into their bodies 3. Erythroblastosis fetalis: may occur when Rh- negative mother carries a second Rh-positive fetus; caused by mother’s Rh antibodies reacting with baby’s Rh-positive cells.

8 Liquid fraction of whole blood minus formed elements.  Composition: Water containing many dissolved substances including: a. Foods, salts b. about 3% of total 02 transported in blood c. About 5% of total CO2. d. Most abundant solutes dissolved in plasma are plasma proteins (1) Albumins (4) Fibrinogen (2) Globulins (5) Prothrombin  Serum: Plasma minus clotting factors (a) Serum is liquid remaining after whole blood clots (b) Serum contains antibodies

9 A. Most blood diseases result from failure of myeloid and lymphatic tissues ( 1).Causes include toxic chemicals, radiation, inherited defects, nutritional deficiencies and cancers, including leukemia. B. Aspiration biopsy cytology (ABC) permits examination of blood-forming tissues to assist in diagnosis of blood diseases. C. Bone marrow, cord blood, and hematopoietic stem cell transplants may be used to replace diseased or destroyed blood-forming tissues

10 A. Characteristics: 1. Biconcave disk shape ( thin center and thicker edges) results in large cellular surface area. 2. Tough and flexible plasma membrane deforms easily allowing RBC to pass through small diameter capillaries 3. Absence of nucleus and cytoplasmic organelle limits life span to about 120 days but provides more cellular space for red pigment called hemoglobin 4. Named according to size : normocytes ( normal size about 7 to 9 um in diameter); microcytic (small size ); macrocytic (large size) 5. Named according to hemoglobin content of cell: normochromic (normal Hb content); hypochromic (low Hb content); Hyperchromic (high Hb content)

11 B. General Functions I. Transport of respiratory gases ( O2 and CO2) a) Combined with hemoglobin (1) Oxyhemoglobin (Hb+O2) (2) Carbaminohemoglobin (Hb+CO2) b) CO2 inside the RBC as bicarbonate II. Important role in homeostasis of acid-base balance

12 A. Polycythemia (overproduction of RBCs) 1. Cause is generally cancerous transformation of red bone marrow 2. Dramatic increase in RBC numbers- often in excess of 10 million/mm3 of blood; hematocrit may reach 60% 3. Signs and symptoms include: a. Increased blood viscosity or thickness b. Slow blood flow and coagulation problems c. Frequent hemorrhages d. Distension of blood vessels and hypertension 4. Treatment may include: a. Blood removal b. Irradiation and chemotherapy to suppress RBC production

13 B. ANEMIA: 1. Caused by low numbers or abnormal RBCs or by low levels or defective types of hemoglobin (Normal Hb levels: g/100 ml of blood-Low Hb level: below 9g/100 ml of blood, classified as anemia) 2. Majority of clinical signs of anemia related to low tissue oxygen levels a) Fatigue; skin pallor b) Weakness; faintness; headache c) compensation results in increased heart and respiratory rates.

14 ANEMIA (continuation) 3. Types: a) Hemorrhagic anemia (1) Acute- blood loss is immediate (for example, surgery or trauma) or chronic-Blood loss occurs over time (for example, ulcers or cancer) b) Aplastic anemia (1)Characterized by low RBC numbers and destruction of bone marrow (2) Often caused by toxic chemicals, irradiation, or certain drugs c) Deficiency anemias caused by inadequate supply of some substance needed for RBC or hemoglobin production I. Pernicious Anemia (1) caused by Vitamin B12 deficiency (2) Genetic-related autoimmune disease (3) decrease RBC, WBC, and platelet numbers

15 Anemia (cont’)  Deficiency anemias: Pernicious anemia(cont’) (4) RBCs are macrocytic (5) Classic symptoms of anemia coupled with CNS impairment (6) Treatment is repeated vitamin B12 injections.

16 Deficiency Anemias (cont’ II. Iron Deficiency anemia (1) Caused by deficiency or inability to absorb iron needed for Hb synthesis (dietary iron deficiency is common worldwide). Bleeding is the most common cause: a) Newborn and children: bleeding Merckel diverticulum b) bleeding peptic ulcer in males < 50 years or older c) menorrhagia in females < 50 years of age d) GI bleeding (polyp, colorectal cancer) in both males and females older than 50 years of age. (2) RBCs are microcytic and hypochromic (3) Hematocrit is decreased (4) Treatment is oral administration of iron compounds

17  Hemolytic anemia: caused by decreased RBC life span or increase RBC rate of destruction.  Symptoms: in addition to the regular symptoms of anemia, the following are characteristics of Hemolytic anemia. 1. Jaundice 2. Swelling of spleen, gallstone formation 3. Tissue iron deposits (Symptoms are related to the retention of RBC breakdown products).

18 Hemolytic Anemia (cont’)  Examples of hemolytic anemia: A. Sickle Cell anemia: (a) Genetic disease resulting in formation of abnormal hemoglobin (HbS); primary found in black people (1 in every 600 African American newborns) (b) RBCs become fragile and assume sickled shape when blood oxygen levels decrease (c) Mild sickle cell trait-result of one defective gene. (d) More severe sickle cell disease-result of two defective genes.

19 Examples of hemolytic Anemia (cont’)  Thalassemia: group of inherited hemolytic anemias (autosomal recessive disorder) occurring primarily in people of mediterranean descent, southeast Asians and in African Americans. (a) decrease in alpha-globin chain synthesis on chromosome 16 due to gene deletion (alpha-thalassemia) or beta-globin chain synthesis on chromosome 11 (beta-thalassemia) (b) RBCs microcytic and short lived (c) Present as mild thalassemia trait and severe thalassemia major (d) Hb levels often fall below 7g/100ml of blood in thalassemia major (e) Classic symptoms of anemia coupled with skeletal deformities and swelling of spleen and liver (f) Marrow and stem cell transplantation needed for long-term treatment.

20 Type Of Hemolytic anemia: (cont’) 3. Erythroblastosis fetalis: (a) Caused by blood ABO or Rh factor incompatibility during pregnancy between developing baby and mother. (b) Maternal antibodies against “foreign” fetal RBCs or Rh factor can cross placenta, enter the fetal circulation, and destroy the unborn baby’s red cell. (c) Symptoms in developing fetus related to decline in RBC numbers and Hb levels; Jaundice, intravascular coagulation, and heart and lung damage are common (d) Treatment may include in utero blood transfusion and premature delivery of the baby. (e) Prevention of Rh factor incompatibility now possible by administration of RhoGAM to Rh negative mothers.

21  General function is protection of body from microorganisms by phagocytosis or antibody formation A. WBC Count: Normal range is 5,000 to 10,000/mm3 1. Leukopenia: total numbers below 5,000 /mm3 of blood. (infrequent but may occur with malfunction of blood- forming tissues or diseases affecting immune system, such AIDS) 2. Leukocytosis : total WBC numbers over 10,000/mm3 of blood (a) Frequent finding in bacterial infections (b) classic sign in blood cancers (leukemia) 3. Differential WBC count : component test in CBC; measures proportions of each type of WBC in blood sample

22 Types and functions A. Granulocytes: Neutrophils; eosinophils; basophils (a). Neutrophils (1). Most numerous type of Phagocyte (2). Numbers increase in Bacterial infections (b). Eosinophils (1). Weak phagocyte (2). Active against parasites and parasitic worms (3). Involved in allergic reactions (c). Basophils: (1). Related to mast cells in tissue spaces (2). Both mast cells and basophils secrete histamine (related to inflammation) (3). Basophils also secrete heparin (an anti-coagulant)

23 B. Agranulocytes: Monocytes in peripheral blood (macrophage in tissues); Lymphocytes: “B lymphocytes” (plasma cells) and “T lymphocytes” a. Monocytes (1) largest leukocyte (2) Aggressive phagocyte: capable of engulfing larger bacteria and cancer cells (3) Develop into much larger cells called macrophages after leaving blood to enter tissues spaces b. Lymphocytes (1) B lymphocytes involved in Immunity against disease by secretion of antibodies (2) Mature B lymphocyte called plasma cells (3) T Lymphocytes involved in direct attack on bacteria or cancer cells (not antibody production)

24 WBC Cancers: may be originated from B and T lymphocyte precursor or their descendent cell types (lymphoid neoplasms), or from malignant transformation of precursor cells of granulocytic WBCs, monocytes, RBCs, and platelets.  Multiple Myeloma: 1. Cancer of B limphocytes called plasma cells 2. Most deadly blood cancer in people over age of Causes bone marrow dysfunction and production of defective antibodies 4. Characterized by recurrent infections and anemia and destruction and fracture of bones 5. treatment includes chemotherapy, drug, antibody therapy, and marrow and stem cell transplantation

25 Leukemias: Malignant neoplasm of the hemopoietic stem cells characterized by:  1. diffuse replacement of the bone marrow by neoplastic cells.  2. Identified as: a. Acute: Acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL). Characterized replacement of the bone marrow with very immature cells (called Blast) and a paucity of mature cells. Blast, which are lymphoid in origin are called lymphoblasts. Most other blasts, are referred to as myeloblasts. -Rapid development of symptoms b. Chronic: Chronic myelogenous leukemia (CML) is characterized by the Philadelphia chromosome and chronic lymphocytic Leukemia (CLL ) which is a proliferative disorder of mature B cells.-Slow development of symptoms, presence of organomegally with lymphoadenopathy and a very high white cell count. Lymphocytes are small cells. Damaged lymphocytes are plentiful and are referred to as smudge cells

26 Chronic Lymphocytic Leukemia (CLL) 1. Average age of onset is 65; rare before age of More common in men than in women 3. Often diagnosed unexpectedly in routine physical exams with discovery of marked B lymphocyte leukocytosis 4. Malignant precursor B lymphocytes are produced in great numbers and spread from the bone marrow to the lymph nodes and other lymphoid tissues. Splenomegaly may occur. 5.Generally mild symptoms include anemia, fatigue, and enlarged- often painless- lymph nodes. In late disease: neutropenia, thrombocytopenia, decreased immunoglobulin production. 6. Most patients live many years following diagnosis 7. Treatment of severe cases involves chemotherapy and irradiation

27 Acute lymphocytic leukemia: 1. Primarily a disease of children between 3 and 7 years of age; 80% of children who develop leukemia have this form of the disease. 2. Highly curable in children but less so in adults 3. Onset is sudden: marked by fever, leukocytosis, bone pain, and increases in infections 4. Lymph node, spleen and liver enlargement is common 5. treatment includes chemotherapy (methrotrexate, mercaptopurine, prednisone, vincristine…), irradiation, and bone marrow or stem cell transplantation

28 Chronic myeloid leukemia (CML) 1. Account for about 20% of all cases of leukemia 2. Occurs most often in adults between 25 and 60 years of age 3. Caused by cancerous transformation of granulocytic precursor cells in the bone marrow 4. Onset and progression of disease is slow with symptoms of fatigue, weight loss, and weakness 5. Diagnosis often made by discovery of marked granulocyte leukocytosis and extreme spleen enlargement 6. Treatment by new “designer drug” Gleevec or bone marrow transplantation is curative in more than 70% of cases

29 Acute myeloid leukemia (AML) 1. Account for 80% of all cases of acute leukemia in adult and 20% of acute leukemia in children 2. Characterized by sudden onset and rapid progression 3. Symptoms include leukocytosis, fatigue, bone and joint pain, spongy bleeding gums, anemia, and recurrent infections 4. Prognosis is poor with only about 50% of children and 30% of adults achieving long-term survival 5. Bone marrow and stem cell transplantation has increased cure rates in selected patients.

30 Infectious mononucleosis 1. Non cancerous WBC disorder caused by Epstein- Barr virus(herpes virus) present in saliva of infected individuals 2. Highest incidence between 15 and 25 years of age 3. Leukocytosis of atypical lymphocytes with abundant cytoplasm and large nuclei 4. Symptoms include fever, severe fatigue, sore throat, rash, and enlargement of lymph nodes and spleen 5. Generally self-limited and resolves without complications in about 4 to 6 weeks

31  A 62-year-old woman complains of fatigue and numbness of her arms and legs for 1 month. She has a history of hypothyroidism and takes thyroid replacement therapy. A complete blood count (CBC) shows WBCs 4000/mm3 (normal: ,800), Hb 9g/dL (normal: 12-16), hematocrit(Hct) 27% (normal: 36-46), mean corpuscular volume (MCV) 120 femtoliters (fL) (normal: ), and platelets 150,000/mm3 (normal: 150, ,000) A peripheral blood smear showed megaloblastic red blood cells with enlarged erythrocytes with hypersegmented neutrophils.  A. What is the most likely diagnosis?  B. What is the Biochemical basis for this disorder?

32  Q.1. Most likely Diagnosis: Pernicious anemia.  Q.2. This patient has a history of thyroid disease and present with findings of megaloblastic anemia with enlarged erythrocytes with hypersegmented neutrophils. The two possibilities are folate and vitamin B12 deficiencies; both of these vitamin deficiencies can lead to defective DNA synthesis, specially thymidine synthesis. Abnormally large red blood cells result from defects in cell maturation and division, whereas RNA synthesis and cytoplasm growth are not affected. Folate deficiency is particularly common in individuals who abuse alcohol. Vitamin B12 stores usually last for several years, but deficiencies may occur in patients with inadequate intrinsic factor, which is needed for vitamin B12 absorption in the ileum. Intrinsic factor is secreted by the parietal cells of the gastric fundus. Vitamin B12 is involved in propionate metabolism. Deficiency of B12 leads to accumulation of methylmalonic acid and propionic acid, which produces demyelination in the spinal cord (that explains abnormal gait, loss of vibratory sensation… etc)

33 A 48-year-old man who works as an accountant complains of weakness, fatigue, and bleeding from the gums when he brushes his teeth. A CBC shows severe pancytopenia with WBC 1000/mm3 (normal: ,800), Hgb 8g/dL (normal: 13-17), hematocrit (Hct) 24% (normal: 41-53),MCV 10 fL (normal: ), and platelets 30,000/mm3 (normal:150, ,000). A. What is the most likely diagnosis? B. What are the laboratory and clinical findings. C. What are the possible causes of this situation?

34  Q.1. Most likely diagnosis: Aplastic Anemia (suppression or destruction of the trilineage myeloid stem cells) Characterized by a pancytopenia expressed by anemia, leukopenia, and thrombocytopenia.  Q.2. Laboratory findings: Panhypoplasia of the marrow with associated leukopenia, and thrombocytopenia. Clinical findings include Fever( infection associated with neutropenia) bleeding (thrombocytopenia), fatigue (anemia)  Q.3. Etiology: Drugs(e,g.,chloramphenicol, chemotherapy agents); Infection (papovirus B19, which also produces pure RBC aplasia); Chemical (e.g., benzene), irradiation

35  A 4-year-old boy is seen by his pediatrician for easy bruising, joint pain, and leg pain; red dots on the skin that do not blanch; and hepatosplenomegaly. The complete blood count reveals an elevated WBC count (50,000/mm3), a low hemoglobin level (anemia), and thrombocytopenia. Examination of the peripheral smear of the blood shows numerous cells with a high nuclear to cytoplasmic ratio, and fine chromatin; the complete blood count shows anemia and thrombocytopenia. A. What is the most likely diagnosis? B. What other investigations need to be done? C. what is the Etiology of this disorder?

36  Q.1. Most likely diagnosis: Acute leukemia, most likely acute lymphoblastic leukemia ( leg and joint pain, fever, enlarged spleen and liver, petechiae. These manifestations usually are due to infiltration of the bone marrow with malignant cells or malignant proliferation cells in the liver and spleen. ALL is more common in children than AML. Children with Down syndrome and those exposed to radiation are at increased risk. )

37  Q.2. Additional studies that should be performed are: Bone Marrow examination for differential count of the cells and the morphology of the cells for evaluation. Flow cytometry (for immunophenotypic studies), and Cytogenetic studies (reliable independent indicators of prognosis…)  Q.3. Etiology: The etiology of acute leukemia is unknown, but genetic, environmental and occupational factors are thought to contribute in some cases. Chemotherapeutic agents, especially alkylating agents, increase the risk of developing AML.

38  A 39-year-old woman who presented with increasing fatigue and muscle weakness is found to have a microcytic and hypochromic anemia. What is the most likely cause of her anemia? A. Folate deficiency B. Iron deficiency C. Viral infection D. Vitamin B12 deficiency E. Vitamin C deficiency

39  “B” The most common causes of microcytic hypochromic anemia are iron deficiency, anemia of chronic disease, thalassemia, and sideroblastic anemia. Among these conditions, the most common cause of microcytic hypochromic is a deficiency of iron. Causes of iron deficiency include a dietary deficiency of iron, decreased intestinal absorption of iron, increased demand for iron, and chronic blood loss.

40  Which one of the following autoantibodies is most likely to be present in a patient with pernicious anemia? A. Anticentromere antibodies B. Antigliadin antibodies C. Anti-intrinsic factor antibodies D. Antimitochondrial antibodies E. Anti-smooth muscle antibodies

41  “C” In contrast to iron deficiency, which causes a microcytic hypochromic anemia, vitamin B12 deficiency produces a macrocytic anemia. The most common cause of Vitamin B12 deficiency in adults is pernicious anemia which is an autoimmune disease characterized by the formation of autoantibodies against intrinsic factor and parietal cells of the stomach. A gastric biopsy from an individual with pernicious anemia will show chronic inflammation with atrophy (chronic atrophic gastritis).

42  A 61-year-old woman with pancytopenia, mild jaundice, and peripheral neuropathy is found to have decrease serum levels of vitamin B12. Which of the abnormal cell morphologies listed below is most likely to be present in a smear made from her peripheral blood? A. Hypersegmented PMNs B. Large granular lymphocytes C. Oval microcytes D. Pelger-Huet neutrophils E. Plasmocytoid lymphocytes

43  “A” The two most common causes of megaloblastic anemia are deficiencies of Vitamin B12 or folate. These deficiencies decrease the synthesis of DNA, which results in nuclear-cytoplasmic asynchrony in maturation, which is the hallmark of megaloblastic anemias. This abnormal maturation will produce characteristic histologic changes in the cells in the peripheral blood, including oval macrocytes and hypersegmented PMNs, which are neutrophils with more than five lobes to their nuclei.

44  A 35-year-old woman with a history of Hepatitis C infection presents with increasing fatigue. Physical examination finds pallor of the skin and conjunctiva and multiple petechial hemorrhages on the skin. No hepatomegaly or splenomegaly is present. A complete blood cell count finds pancytopenia. Which of the following bone marrow findings is most consistent with a diagnosis of aplastic anemia? A. Absolute erythroid hyperplasia B. General lymphoid hyperplasia C. Relative marrow hypoplasia D. relative erythroid aplasia E. relative granulocytic hypoplasia

45  “C” Aplastic anemia is characterized by marked hypoplasia of all the cells in the bone marrow. The decrease in the erythroid, granulocytic, and megakaryocytic cell lines in the bone marrow will decrease all cell lines(pancytopenia) in the peripheral blood.

46  A 66-year-old man presents with signs and symptoms of anemia. Examination of his peripheral blood smear reveals the abnormal presence of nucleated red blood cells and myelocytes. What is the best diagnosis? A. Aplastic anemia B. Digeorge syndrome C. fanconi anemia D. myelophthisic anemia E. Potter syndrome

47  “D” The term myelophthisic anemia refers to anemia caused by a space-occupying lesion within the bone marrow. Causes of myelophthisic anemia include metastases to the bone marrow, granulomas, and fibrosis (myelofibrosis). With myelophthisis anemia, the peripheral blood smear will show both immature RBCs (nucleated red blood cells) and immature WBCs (myelocyte). This abnormality of the peripheral blood also is known as leukoerythroblastosis.

48  Which one of the laboratory tests listed below would best differentiate hypersplenism from aplastic anemia as being the cause of peripheral pancytopenia? A. Direct Coombs test B. Ham test C. Metabisulfite test D. reticulocyte test E. sugar water test

49  “D” Hypersplenism can cause destruction of red blood cells, white blood cells, and platelets within the spleen by the splenic macrophage. With hypersplenism, the bone marrow will be hypercellular and the peripheral reticulocyte count will be elevated. This is in contrast to aplastic anemia, in which the bone marrow will be hypocellular and the reticulocyte count will be low.

50 Abnormal hemostasis:  Hemostasis requires a dynamic balance between factors that promote clot formation and factors that promote anticoagulation.  The tendency to bleed or to clot can be inherited or acquired  The type of bleeding problems you encounter in the outpatient setting are likely to be quite different from the bleeding problems you might see in hospitalized patients

51 Most common causes of Abnormal bleeding  Von Willibrand’s disease (vWD) is the most likely inherited cause; It is due to a lack of the protein that links platelets to damaged endothelium.  The most common acquired cause is NSAIDs and aspirin, with bleeding in 10% of patients taking these agents  Idiopathic thrombocytopenic Purpura (ITP): is an acquired disease caused by autoantibodies that bind to the surface of platelets and shorten their life span.(these Abs may be associated with systemic diseases, including SLE, HIV infection, and lymphoproliferative disorders.)  ITP is usually an outpatient diagnosis.

52 Most likely causes of bleeding in a hospitalized Patient:  In the ICU dissaminated intravascular coagulation (DIC) is a common cause of abnormal bleeding. This is a final common pathway of many conditions, including sepsis, massive trauma and transfusion, acute head injury, acute promyelocytic leukemia, and adenocarcinioma  Liver disease with its associated Vitamin K- dependent factor deficiency (II, VII, IX, X)

53 Platelets:  1. play essential role in blood clotting a. Blood vessel damage causes platelets to become sticky and form a “platelet plug b. Accumulated platelets release additional clotting factors that enter into the clotting mechanism c. Platelets ultimately become a part of the clot itself

54 Clotting mechanism 1. Damage tissue cells release clotting factors leading to formation of prothrombin activator, which combines with platelet-produced prothrombin activator 2. Prothrombin activator and calcium convert prothrombin to thrombin 3. Thrombin reacts with fibrinogen to form fibrin 4. Fibrin threads form a tangle to trap RBCs and other formed elements to produce a blood clot

55 Altering the blood clotting mechanism 1. Application of gauze (rough surface) to wound causes platelet aggregation and release of clotting factors 2. Administration of Vitamin K will increase synthesis of prothrombin 3. Drug Coumadin will delay clotting by inhibiting prothrombin synthesis 4. Heparin delays clotting by inhibiting conversion of prothrombin to thrombin 5. Laboratory tests used to monitor effectiveness of anticoagulant therapy include: a. Prothrombin time-reported in seconds ( 7 to 10sec. Normal) b. INR (International Normalized Ratio)-a calculated value reported as a number (0.8 to 1.2 is normal)

56  1.Thrombus: stationary blood clot  2. Embolus: circulating blood clot (drug called “Tissue Plasmogen Activator”-TPA- used to dissolve clots that have already formed)  3. HEMOPHILIA: most serious “bleeding disease” worldwide (a). Hemophilia A : most common form. X-linked inherited disorder results from inability to produce factor VIII (a plasma protein) responsible for blood clotting (b). In severely affected individuals frequent and extensive episodes of bleeding can be life-threatening (c.) Characterized by easy bruising, deep muscle hemorrhage, blood in urine, and repeated episodes of bleeding into joints causing pain and deformity. (d). Treatment includes administration of factor VIII, injury prevention, and avoiding drugs such as aspirin that alter the clotting mechanism

57 Thrombocytopenia: caused by reduced platelet counts A. Characterized by bleeding from small blood vessels, most visibly in the skin and mucous membranes B. Platelets count below 20,000/mm3 may cause catastrophic bleeding (normal platelet count 150, ,000/mm3) C. Thrombocytopenia may stem from: (1)Failed platelet production (2) Splenic sequestration of platelets (3) increased destruction or use, or dilution of platelets Most common is bone marrow destruction by drugs, chemicals, radiation, and diseases such as cancer, lupus and HIV/AIDS D. Treatment may involve transfusion of platelets, corticosteroid types drugs or removal of the spleen

58  A 16-year-old man complains of pain and swelling in his knee joints after playing basketball yesterday. He had a similar episode last summer at the start of basketball season and he stopped playing until yesterday. His laboratory examination shows a normal platelet count, normal bleeding time, normal prothrombin time(PT), and prolonged partial thromboplastin time (PTT). He most likely has which disease? A. Vitamin K deficiency B. Disseminated intravascular coagulation (DIC) C. von Villebrand’s disease D. Hemophilia A E. Hemolytic-uremic syndrome

59  “d”, Characteristically, persons with hemophilia A develop bleeding into traumatized joints; especially when the joints sustained previous trauma, and their laboratory tests reveal only an abnormal PTT. Persons with vitamin K deficiency, until it becomes severe, usually show a prolonged PT and a normal PTT; persons with a milder form of DIC have thrombocytopenia and prolonged PT, PTT, and TT; and persons with mild inherited von Willebrand’s disease also bleed after trauma and show a prolonged bleeding time as well as reduction in plasma concentration of von Willebrand’s factor and reduced factor VIII activity. Hemolytic-Uremic syndrome is caused of DIC.

60  A 23-year-old man complains of epistaxis, echymoses of the face and neck, thorax pain, and swelling of the wrist joint of the right hand after a serious fight with another young man. Otherwise, he has felt well except for persistent diarrhea for the past few weeks because of a flare-up of his Crohn’s disease. His laboratory examination shows a normal partial platelet count, normal bleeding time, prolonged prothrombin time (PT), and a normal partial thromboplastin (PTT). He most likely has which disease? A. Vitamin K deficiency B. Disseminated intravascular coagulation (DIC) C. von Villebrand’s disease D. Hemophilia E. Hemolytic-uremic syndrome

61  “a” Vitamin K deficiency, until it becomes severe, usually show prolonged PT and a normal PTT, evidence of bleeding, and in this patient the loss of vitamin K derives from maladsorption. When the vitamin K deficiency becomes severe, the affected person also develops a prolonged PTT in the face of the loss of other coagulation factors. Persons with Hemophilia A show an abnormal PTT; persons with a milder form of DIC have thrombocytopenia and prolonged PT,PTT, and TT; and persons with mild inherited von Willebrand’s disease also bleed after trauma and show a prolonged bleeding time as well as reduction in plasma concentration of von Willebrand’s factor and reduced factor VIII activity. Hemolytic- uremic syndrome is cause of DIC.

62 Clinical Symptoms Likely Bleeding Problem  Bruising ……………………. ………………… Connective tissue disorder ( Ehlers-Danlos Syndrome, scurvy) Vitamin K deficiency  Bruises on extremity Extensor surfaces……….. ………..………………………………………………..Physical abuse  Delayed (hours-days) postsurgical bleeding……………………….. ……………………………………..Hemophilia, Vit. K deficiency factor deficiency ( secondary hemostasis problem)  Joint or deep muscle bleed……………………………………………………….Hemophilia  Oozing catheter site in Hospitalized patient …………………… ……..……… DIC  Palpable purpura………………………………………….…………………Vasculitis, cryoglobulinemia, endocarditis  Petechiae,mucosal hemorrhage, bruises from minor trauma…………………………………….Decreased or dysfunctional platelets (primary hemostasis problem)

63 Inherited Causes of Hypercoagulability: ( autosomal dominant)  Deficiencies of the physiologic anticoagulant proteins C and S and antithrombin III in 5% to 15% of patients < 45 years old with DVT  Activated protein C resistance (also called factor V Leiden mutation) may be diagnosed in 50% of patients with recurrent DVT. This is common in women who develop blood clots while taking oral contraceptive (less common in Asians and African Americans)  A prothrombin (G20210A) polymorphism has been identified more recently as associated with an increased risk of thromboembolism and MI in young patients (2% prevalence in white)  Hyperhomocysteinemia is associated with arterial and venous clots.

64 Risk factors for arterial thrombosis `  Hypertension  Hyperlipidemia  Elevated Lp(a) lipoprotein  Diabetes  Smoking  Vasculitis Risk factors for venous clotting  Immobilization  Anesthesia  Surgery,  pregnancy,  Estrogen use  Malignancy

65 A 37-year-old woman with a history of RA presents with a new rash around her ankles and multiple dime- to quarter- sized bruises on her arms after working in her garden. She denies any recent illness or problems with bleeding or bruising in the past and takes no medications. On exam, there are palatal petechiae. There are several purpuric lesions on each of her forearms, all <1.5 cm in diameter and most < 1 week old. There is no adenopathy or organomegalia. The rash around her ankles consists of nearly confluent, nonblanching, pinpoint erythematosous lesions. A. What is the most likely diagnosis, and how is her history of RA relevant? B. What lab studies would you order to investigate this? C. What do you recommend for therapy

66  A. The most likely diagnosis is ITP. The patient’s autoimmune history and RA put her at risk to develop additional autoimmune complications such as ITP  B. CBC would yield the most pertinent information  C. Treat ITP appropriately with steroids; add IVIG only if acute bleeding is present.

Download ppt "By Georges Metellus, M.D., M.P.H. American University of Antigua Miami Site."

Similar presentations

Ads by Google